OCUL
Ocular TherapeutixยทNASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
OCUL Profile
Ocular Therapeutix, Inc.
A biopharmaceutical company focused on innovative therapies for diseases and conditions of the eye
15 Crosby Drive, Bedford, MA 01730
--
Ocular Therapeutix, Inc., was established in Delaware on September 12, 2006. The company is a biopharmaceutical company dedicated to improving people's vision and quality of life by developing and commercializing innovative therapies for eye diseases and conditions, with a special focus on retinal diseases. The company's hydrogel-based bioabsorbable product candidate is designed to provide sustained release of therapeutic drugs to the eye. The Company's lead product candidates are drug-eluting punctal plug OTX-DP and punctal OTX-TP inserted into a natural opening called the punctum located on the inner part of the eyelid near the nose. The Company's canalicular suppository product candidate combines the Company's hydrogel technology with the U.S. Food and Drug Administration, or FDA-approved therapeutic drug for the purpose of providing continuous dosing to the eye.
